Certara, Inc. is a global leader in biosimulation science, technology, and consulting services that transform drug development through model-informed drug development (MIDD). The company provides prop... Certara, Inc. is a global leader in biosimulation science, technology, and consulting services that transform drug development through model-informed drug development (MIDD). The company provides proprietary biosimulation platforms, software products, and expert consulting services designed to help biopharmaceutical and biotech organizations design better clinical trials, optimize drug development decisions, and accelerate regulatory approval processes. Certara's software solutions include mechanistic and empirical biosimulation models, pharmacometric analysis tools, and the Pinnacle 21 family of clinical data management products. The company also offers specialized services spanning drug development strategy, clinical pharmacology, regulatory science, and submission management across major health agencies including the FDA, EMA, and China's NMPA. In 2024, Certara acquired Chemaxon to strengthen its drug discovery capabilities through chemical property prediction and in-silico development tools. The platform integrates artificial intelligence capabilities within validated scientific frameworks to enhance modeling productivity and data connectivity. Certara's solutions serve more than 2,600 life sciences organizations globally, including 38 of the top 40 biopharmaceutical companies by R&D spend, with customers receiving the majority of novel drug approvals from the FDA. Founded in 2008 and headquartered in Radnor, Pennsylvania, Certara operates across the Americas, Europe, Middle East, Africa, and Asia Pacific.
Disclosures of Certara
Explore Certara's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Certara's official channels and fully traceable to its official company sources.
The table below lists all of Certara's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.
Fiscal Year / Type
Languages
20261 disclosure
DEF 14A
en
20244 disclosures
10-K
en
ESG Report
en
ESG Report
en
Financial & Extra-Financial Disclosure
en
20233 disclosures
ESG Report
en
10-K
en
Financial & Extra-Financial Disclosure
en
20221 disclosure
10-K
20212 disclosures
10-K
ESG Report
20201 disclosure
10-K
Real-Time Disclosures Datafeed
Get Notified Within Seconds of New Corporate Disclosures
Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?
Account Restricted
Your account has been restricted and you no longer have access to paid features.
Contact our support team orupgrade your planto unblock your account.